For years I believed the little dip-then-climb on a child’s growth chart the way you believe the tide tables: the body mass index falls through the toddler years, bottoms out, and then around age six it “rebounds,” and if that rebound comes early it was supposed to be the first quiet warning that fat was creeping back on for good. Pediatricians chart it. Papers build careers on it. And for 42 years the field read that rebound as fat without once setting an actual fat measurement beside it.

So a researcher finally set one there. The waist told a completely different story than the scale.

The theory has a name and a birthday. In 1984, the French nutrition researcher Marie Françoise Rolland-Cachera and her colleagues, writing in The American Journal of Clinical Nutrition, described what they called the “adiposity rebound,” the second upward turn of the BMI curve that usually shows up between six and eight years old. Their longitudinal data suggested that kids whose curve turned up early, before about five and a half, carried more adiposity into adulthood, a claim the same group was still defending as recently as 2021. The idea stuck. Four decades on, an early adiposity rebound is still taught as one of the earliest flags for later obesity and metabolic disease, the kind of thing that can drop a normal, growing five-year-old into a risk conversation.

The theory rests on an assumption it never says out loud. BMI is weight over height squared. It cannot tell the difference between a kilogram of fat and a kilogram of muscle or bone. So when the curve turns up at six, calling it an adiposity rebound is a guess, a reasonable-sounding one, but a guess. And this is exactly the moment in childhood when kids stop being round toddlers and start putting on lean tissue, lengthening, building the muscle and bone that carry them into adolescence.

So Andrew Agbaje, a physician-epidemiologist at the University of Eastern Finland, went and measured the waist instead. He pulled 2,410 American children and teenagers, ages 2 to 19, from the 2021 to 2023 cycle of NHANES, the big federal health survey, and tracked their waist-circumference-to-height ratio across that whole age span. Waist-to-height ratio is the cheap, unglamorous tape-measure number that happens to estimate body fat with around 90 percent accuracy against DEXA, the gold-standard body-fat scan. It is a validated stand-in for fat, where BMI is only a stand-in for mass.

And it never rebounded. The BMI did its familiar thing, sinking from 17.1 at age two and then climbing back to that same 17.1 by age six before rising on. But the waist-to-height ratio, which sat around 0.54 at age two, just kept falling, down through age seven, past the point where BMI insists the fat is returning, and it never climbed back to where it started. Same children, two numbers, opposite stories. The scale-based number rises; the waist-based fat marker keeps going down.

Wait, so what is climbing? This is where the biology got me, because once you say it out loud it’s almost obvious: it’s the lean tissue. The muscle a six-year-old is packing onto lengthening bones. The skeleton itself getting denser and heavier. That mass pours onto the scale and lands in the BMI, and because BMI is blind to what kind of mass it is, we spent 42 years reading a growth spurt as a fat problem. “Children in effect undergo a body composition reset at the plateau around age 4 years,” Agbaje said, “which prepares them for the growth stages after that age.” A reset, not a relapse. Growing, it turns out, looks a lot like the warning sign for the disease we invented to explain growing.

One honest limit, because the establishment’s whole mistake here was overreaching from a proxy and I am not going to do it in reverse. This is a cross-sectional snapshot: different kids at each age, measured once, not the same children followed for years the way Rolland-Cachera followed hers. It can show that at the population level fat is not rebounding, and it can gut the assumption that the BMI climb is fat. It cannot by itself settle the separate, longitudinal claim that a kid whose BMI turns up early tends to be heavier at 21. Those are two different questions, and a fair reading keeps them apart. What the waist data kills is the interpretation everyone hung on that curve.

There is one more thread worth pulling. Agbaje’s paper is his lecture as the inaugural winner of the Flemming Quaade Award for innovation in childhood obesity, an honor jointly sponsored by the American Society for Nutrition Foundation and the Novo Nordisk Foundation, the charitable enterprise that holds controlling ownership of Novo Nordisk itself. Novo Nordisk makes Wegovy, the GLP-1 drug the FDA cleared for adolescents as young as 12 in December 2022, and its market grows every time another kid gets labeled at risk. The finding cuts directly against that interest. A researcher standing on a Novo-linked platform used it to argue that we over-diagnose children, that a normal growth pattern has been miscast as early obesity, that BMI alone should not be labeling anyone. When the money’s own prize goes to the person telling clinicians to stop flagging healthy six-year-olds, you notice. The disclosure listed no conflict of interest and the study’s own funding was not stated, which tells you something about how loosely these lines get drawn.

The practical stakes are simple, and they are about your kid, not a curve. A waist-to-height ratio under about 0.5, “keep the waist to less than half the height,” is the reassuring number, and it costs a tape measure. Agbaje points out that recent global consensus statements already say obesity should not be diagnosed on BMI alone and should be confirmed with measures like waist-to-height ratio; this is the pediatric data pushing the same direction. If it spares even a fraction of kids from being told at five that their body is heading somewhere it is not, that beats the theory it retires.

So here is my conclusion. If a chart ever tells me a growing six-year-old has “rebounded,” I am not reaching for a diet plan; I am reaching for a tape measure and checking the waist against half their height before I let anyone put a warning label on a kid who is simply getting bigger the way bodies are supposed to.

Sources

  1. ScienceDaily – “A 42-year-old childhood obesity theory may be wrong” (2026)
  2. The Journal of Nutrition – Agbaje, “Adiposity Rebound or Fat-Free Mass Anabolism in Children,” 2026 (NHANES 2021–2023, 2,410 children)
  3. American Society for Nutrition – “Study Challenges Decades-Old Puzzle About Childhood Body Fat” (Flemming Quaade Award sponsors; Agbaje on BMI diagnosis)
  4. PMC – “Early adiposity rebound: predictors and outcomes,” review of the clinical predictor built on the 1984 theory
  5. PMC – Rolland-Cachera et al., “Early Adiposity Rebound Predicts Later Overweight,” restating the original claim (2021)
  6. PMC – Ashwell & Gibson, “Keep your waist circumference to less than half your height” (the WHtR 0.5 screening rule)
  7. Contemporary Pediatrics – “FDA approves semaglutide for obesity in adolescents” (Wegovy cleared for ages 12+, December 2022)